FDA Approves Second Sight’s Argus II Retinal Prothesis System
NewsMedical reports that the FDA has approved Second Sight Medical Products’ Argus II Retinal Prosthesis System, an implanted device to treat patients with advanced retinitis pigmentosa. According to the story:
a small video camera, transmitter mounted on a pair of eyeglasses, video processing unit (VPU) and an implanted retinal prosthesis (artificial retina), replaces the function of degenerated cells in the retina (a membrane inside the eye) and may improve a patient’s ability to perceive images and movement
The FDA approved the Argus II as a humanitarian device limited to fewer than 4,000 individuals in the United States annually.